3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Paraproteinemias
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Immunoglobulin Light-chain Amyloidosis
1
Interventions
Standard of Care
31
Specimen Handling
27
Interviews as Topic
24
Educational Status
24
Practice Guidelines as Topic
22
Methods
22
Early Intervention, Educational
22
Exercise
19
Blood Specimen Collection
16
Surveys and Questionnaires
12
Radiosurgery
11
Magnetic Resonance Spectroscopy
11
Patient Navigation
10
Palliative Care
9
Counseling
8
Diet Therapy
7
Surgical Procedures, Operative
6
Resistance Training
6
Health Promotion
6
Radiotherapy
5
Nutrition Assessment
5
Magnetic Resonance Imaging
5
Genetic Testing
5
X-Rays
4
Watchful Waiting
4
Positron-Emission Tomography
4
Neoadjuvant Therapy
4
Human Papillomavirus DNA Tests
4
Dietary Supplements
4
Colposcopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
×
30 days
×
Clear all
NCT07624760
2026-06-03
MGUS-PET
University of Zurich
Phase NA
Not yet recruiting
50 enrolled